Search Results for: STEM CELL MARKET Stem Cell
Articles
December 4, 2011
Heparinex Receives $1.6-Million Award to Enable CMC for Proprietary Delivery Technology December 4, 2011
Heparinex, LLC recently announced the company has received a $1.6-million fund endowment from the Economic Development Generating Excellence program (EDGE)....
December 4, 2011
Nanion's SyncroPatch 96 Convinces Big Pharma Automated Patch Clamp Users December 4, 2011
Nanion's ion channel screening platform, the SyncroPatch 96, has been well received within the pharmaceutical industry during the past 12...
November 27, 2011
11/29/2011 November 27, 2011
Biocon Launches Haselmeier's Insulin Pen in India Haselmeier recently announced that Biocon, one of Asia's premier biotechnology companies, has launched...
November 20, 2011
11/22/2011 November 20, 2011
Apricus Biosciences Announces NexACT Partner Has Completed pre-IND Meeting Apricus Biosciences, Inc. recently announced its NexACT out-licensing partner, Exodos Life...
November 10, 2011
11/15/2011 November 10, 2011
Lundbeck & Otsuka Enter Long-Term CNS Agreement, Deal Has $1.8-Billion Potential Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S recently...
November 3, 2011
11/8/2011 November 3, 2011
Gateway Analytical Growth Demands Move to a Larger Facility Gateway Analytical recently announced the company will move to a larger...
November 3, 2011
Repligen Buys Novozymes Biopharma Unit November 3, 2011
Repligen Corporation recently announced the execution of a definitive agreement to acquire the business of Novozymes Biopharma Sweden AB in...
October 27, 2011
11/01/2011 October 27, 2011
Activartis Develops Cancer Vaccine in Phase II, Seeks Partner Activartis GmbH (formerly Trimed Biotech GmbH) recently announced it is developing...
October 27, 2011
Activartis Develops Cancer Vaccine in Phase II, Seeks Partner October 27, 2011
Activartis GmbH (formerly Trimed Biotech GmbH) recently announced it is developing a cancer immunotherapy concept that is currently in Phase...
October 27, 2011
Biogen Idec & Portola Pharmaceuticals Strike $553-Million Deal October 27, 2011
Biogen Idec and Portola Pharmaceuticals, Inc. recently announced they have entered into an exclusive, worldwide collaboration and license agreement under...
October 20, 2011
10/25/2011 October 20, 2011
Abbott to Separate Into Two Leading Companies Abbott recently announced it plans to separate into two publicly traded companies, one...
October 13, 2011
10/17/2011 October 13, 2011
Oncobiologics Announces Two New Agreements Worth Almost $80 Million Oncobiologics recently announced it has signed two major agreements. The first...
October 9, 2011
10/11/2011 October 9, 2011
Carticept Medical Receives 510(k) Clearance for Navigator Delivery System Carticept Medical, Inc., a developer of innovative products for the treatment...
October 9, 2011
Intellect Neurosciences & ViroPharma Announce $126.5-Million Global Licensing Agreement October 9, 2011
Intellect Neurosciences, Inc. recently announced that it has granted an exclusive license to ViroPharma Incorporated regarding certain of Intellect's licensed...
September 27, 2011
10/4/2011 September 27, 2011
Talon Therapeutics' NDA Accepted for Filing by US FDA Under Subpart H Talon Therapeutics, Inc. recently announced its NDA seeking...
September 25, 2011
9/27/2011 September 25, 2011
Thermo Fisher Scientific Introduces New Imaging ATR Accessory Thermo Fisher Scientific Inc., a world leader in serving science, recently announced...
September 18, 2011
Alkermes Launches Corporate Operations in Ireland September 18, 2011
Alkermes plc recently announced the establishment of its corporate operations in Ireland, with new headquarters located in Dublin. The company,...
September 18, 2011
9/20/2011 September 18, 2011
Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices Unilife Corporation recently announced the development of its AutoInfusor portfolio...
September 11, 2011
9/13/2011 September 11, 2011
Evotec & Roche to Develop Compound That Could Slow AD Progression Evotec AG and Roche AG recently announced they have...
September 1, 2011
9/6/2011 September 1, 2011
Jennerex's Virus-Based Drug Targets & Infects Tumors Jennerex, Inc. recently announced the publication of clinical data on its lead product...Company Profiles
December 1, 2023
BD Medical - Pharmaceutical Systems
BD Medical - Pharmaceutical Systems United States 1 Becton Drive Franklin Lakes, NJ 07417 T: +1 800 225 3310 Europe...
